Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR044564-01
Application #
2083995
Study Section
Special Emphasis Panel (ZAI1-MCH-I (45))
Project Start
1996-09-10
Project End
2001-07-31
Budget Start
1996-09-10
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Diatchenko, Luda; Romanov, Sergei; Malinina, Inga et al. (2005) Identification of novel mediators of NF-kappaB through genome-wide survey of monocyte adherence-induced genes. J Leukoc Biol 78:1366-77
Diatchenko, Luda; Slade, Gary D; Nackley, Andrea G et al. (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135-43
Li, Xiangli; Bradford, Blair U; Dalldorf, Frederick et al. (2004) CD14 mediates the innate immune responses to arthritopathogenic peptidoglycan-polysaccharide complexes of Gram-positive bacterial cell walls. Arthritis Res Ther 6:R273-81
Miagkov, A V; Varley, A W; Munford, R S et al. (2002) Endogenous regulation of a therapeutic transgene restores homeostasis in arthritic joints. J Clin Invest 109:1223-9
Makarov, S S (2001) NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res 3:200-6
Makarov, S S (2000) NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 6:441-8
Miagkov, A V; Kovalenko, D V; Brown, C E et al. (1998) NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A 95:13859-64
Makarov, S S; Johnston, W N; Olsen, J C et al. (1997) NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA. Gene Ther 4:846-52